Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Devos

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
AIDS (London, England)|December 21, 2022
Prevalence of HIV drug resistance in Nigeria: results from a cross-sectional, population-based survey of Nigerian adults with unsuppressed viral loadGambo G Aliyu, Jonathan G Lawton, Andrew B Mitchell, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 18, 2002
(E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2'-isobutyl-2'-(methanesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a selective and orally active inhibitor of tumor necrosis factor-alpha convertaseG Beck, G Bottomley, D Bradshaw, et al.
Cell|December 29, 1995
Identification and expression cloning of a leptin receptor, OB-RL A Tartaglia, M Dembski, X Weng, et al.
Antiviral Therapy|August 17, 2022
Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in MalawiGeorge Bello, Matthew Kagoli, Sikhona Chipeta, et al.
AIDS (London, England)|February 18, 2026
HIV-1 variants in population-based national surveys in sub-Saharan Africa, 2015-2022Peter D Ghys, Andrew C Voetsch, Jessica E Justman, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
AIDS (London, England)|December 21, 2022
Prevalence of HIV drug resistance in Nigeria: results from a cross-sectional, population-based survey of Nigerian adults with unsuppressed viral loadGambo G Aliyu, Jonathan G Lawton, Andrew B Mitchell, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 18, 2002
(E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2'-isobutyl-2'-(methanesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a selective and orally active inhibitor of tumor necrosis factor-alpha convertaseG Beck, G Bottomley, D Bradshaw, et al.
Cell|December 29, 1995
Identification and expression cloning of a leptin receptor, OB-RL A Tartaglia, M Dembski, X Weng, et al.
Antiviral Therapy|August 17, 2022
Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in MalawiGeorge Bello, Matthew Kagoli, Sikhona Chipeta, et al.
AIDS (London, England)|February 18, 2026
HIV-1 variants in population-based national surveys in sub-Saharan Africa, 2015-2022Peter D Ghys, Andrew C Voetsch, Jessica E Justman, et al.
Pageof 8